TrialJournal of the American Heart Association2015

Effect of PCSK9 Inhibition by Alirocumab on Lipoprotein Particle Concentrations Determined by Nuclear Magnetic Resonance Spectroscopy.

Michael J Koren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.